Wordt geladen...
How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients
Background: The literature suggests that medical oncologists differ on how they use the Oncotype DX (ODX) genomic assay for making decisions about systemic therapy in breast cancer patients. Given the emergence of data supporting the use of genomic profiling for the prognosis and predicting benefit...
Bewaard in:
| Gepubliceerd in: | Curr Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7985759/ https://ncbi.nlm.nih.gov/pubmed/33557029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28010077 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|